Trial Profile
Does Short-Term Anti-Seizure Prophylaxis After Traumatic Brain Injury Decrease Seizure Rates?
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 09 Aug 2021
Price :
$35
*
At a glance
- Drugs Levetiracetam (Primary)
- Indications Seizures
- Focus Therapeutic Use
- 18 Dec 2017 Status changed from not yet recruiting to recruiting.
- 14 Mar 2017 Planned End Date changed from 15 Feb 2021 to 1 Apr 2021.
- 14 Mar 2017 Planned primary completion date changed from 15 Feb 2020 to 1 Apr 2020.